ParkinsonCanadaV1, PascalFrancis, Curation, bibRecord, 001183

Ropinirole and pramipexole, the new agonists

Identifieur interne : 001183 ( PascalFrancis/Curation ); précédent : 001182; suivant : 001184

Ropinirole and pramipexole, the new agonists

Auteurs : D. E. Hobson [Canada] ; E. Pourcher [Canada] ; W. R. W. Martin [Canada]

Source :

Canadian journal of neurological sciences [ 0317-1671 ] ; 1999.

RBID : Pascal:99-0456205

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Ropinirole, Agoniste, Récepteur dopaminergique D2, Pramipexole, Antiparkinsonien, Chimiothérapie, Traitement, Homme.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Agonist, Antiparkinson agent, Chemotherapy, D2 Dopamine receptor, Human, Parkinson disease, Pramipexole, Ropinirole, Treatment.

A01	`01`	`1`		`@0 0317-1671`
A02	`01`			`@0 CJNSA2`
A03		`1`		`@0 Can. j. neurol. sci.`
A05				`@2 26`
A06				`@3 SUP2`
A08	`01`	`1`	`ENG`	`@1 Ropinirole and pramipexole, the new agonists`
A09	`01`	`1`	`ENG`	`@1 Parkinson's Disease: Challenges and New Advances: Presentations of a series of regional educational programs in 1998`
A11	`01`	`1`		`@1 HOBSON (D. E.)`
A11	`02`	`1`		`@1 POURCHER (E.)`
A11	`03`	`1`		`@1 MARTIN (W. R. W.)`
A14	`01`			`@1 University of Manitoba @2 Winnipeg, Manitoba @3 CAN @Z 1 aut.`
A14	`02`			`@1 Laval University @2 Quebec City, Quebec @3 CAN @Z 2 aut.`
A14	`03`			`@1 University of Alberta @2 Edmonton, Alberta @3 CAN @Z 3 aut.`
A20				`@2 S27-S33`
A21				`@1 1999`
A23	`01`			`@0 ENG`
A24	`01`			`@0 fre`
A43	`01`			`@1 INIST @2 17449 @5 354000089421960050`
A44				`@0 0000 @1 © 1999 INIST-CNRS. All rights reserved.`
A45				`@0 53 ref.`
A47	`01`	`1`		`@0 99-0456205`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Canadian journal of neurological sciences`
A66	`01`			`@0 CAN`
C02	`01`	`X`		`@0 002B02B06`
C02	`02`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Parkinson maladie @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @5 01`
C03	`02`	`X`	`FRE`	`@0 Ropinirole @2 NK @2 FR @5 04`
C03	`02`	`X`	`ENG`	`@0 Ropinirole @2 NK @2 FR @5 04`
C03	`02`	`X`	`SPA`	`@0 Ropinirol @2 NK @2 FR @5 04`
C03	`03`	`X`	`FRE`	`@0 Agoniste @5 05`
C03	`03`	`X`	`ENG`	`@0 Agonist @5 05`
C03	`03`	`X`	`SPA`	`@0 Agonista @5 05`
C03	`04`	`X`	`FRE`	`@0 Récepteur dopaminergique D2 @5 06`
C03	`04`	`X`	`ENG`	`@0 D2 Dopamine receptor @5 06 @6 «D2» Dopamine receptor`
C03	`04`	`X`	`SPA`	`@0 Receptor dopaminérgico D2 @5 06`
C03	`05`	`X`	`FRE`	`@0 Pramipexole @2 NK @2 FR @5 07`
C03	`05`	`X`	`ENG`	`@0 Pramipexole @2 NK @2 FR @5 07`
C03	`05`	`X`	`SPA`	`@0 Pramipexol @2 NK @2 FR @5 07`
C03	`06`	`X`	`FRE`	`@0 Antiparkinsonien @5 08`
C03	`06`	`X`	`ENG`	`@0 Antiparkinson agent @5 08`
C03	`06`	`X`	`SPA`	`@0 Antiparkinsoniano @5 08`
C03	`07`	`X`	`FRE`	`@0 Chimiothérapie @5 16`
C03	`07`	`X`	`ENG`	`@0 Chemotherapy @5 16`
C03	`07`	`X`	`SPA`	`@0 Quimioterapia @5 16`
C03	`08`	`X`	`FRE`	`@0 Traitement @5 17`
C03	`08`	`X`	`ENG`	`@0 Treatment @5 17`
C03	`08`	`X`	`SPA`	`@0 Tratamiento @5 17`
C03	`09`	`X`	`FRE`	`@0 Homme @5 20`
C03	`09`	`X`	`ENG`	`@0 Human @5 20`
C03	`09`	`X`	`SPA`	`@0 Hombre @5 20`
C07	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 37`
C07	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`02`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Encéphale pathologie @5 39`
C07	`03`	`X`	`ENG`	`@0 Cerebral disorder @5 39`
C07	`03`	`X`	`SPA`	`@0 Encéfalo patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 40`
C07	`05`	`X`	`FRE`	`@0 Maladie dégénérative @5 41`
C07	`05`	`X`	`ENG`	`@0 Degenerative disease @5 41`
C07	`05`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 41`
N21				`@1 291`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000D40

Links to Exploration step

Pascal:99-0456205

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Ropinirole and pramipexole, the new agonists</title>
<author><name sortKey="Hobson, D E" sort="Hobson, D E" uniqKey="Hobson D" first="D. E." last="Hobson">D. E. Hobson</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>University of Manitoba</s1>
<s2>Winnipeg, Manitoba</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Pourcher, E" sort="Pourcher, E" uniqKey="Pourcher E" first="E." last="Pourcher">E. Pourcher</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Laval University</s1>
<s2>Quebec City, Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Martin, W R W" sort="Martin, W R W" uniqKey="Martin W" first="W. R. W." last="Martin">W. R. W. Martin</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>University of Alberta</s1>
<s2>Edmonton, Alberta</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">99-0456205</idno>
<date when="1999">1999</date>
<idno type="stanalyst">PASCAL 99-0456205 INIST</idno>
<idno type="RBID">Pascal:99-0456205</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D40</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001183</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Ropinirole and pramipexole, the new agonists</title>
<author><name sortKey="Hobson, D E" sort="Hobson, D E" uniqKey="Hobson D" first="D. E." last="Hobson">D. E. Hobson</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>University of Manitoba</s1>
<s2>Winnipeg, Manitoba</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Pourcher, E" sort="Pourcher, E" uniqKey="Pourcher E" first="E." last="Pourcher">E. Pourcher</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Laval University</s1>
<s2>Quebec City, Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Martin, W R W" sort="Martin, W R W" uniqKey="Martin W" first="W. R. W." last="Martin">W. R. W. Martin</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>University of Alberta</s1>
<s2>Edmonton, Alberta</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Canadian journal of neurological sciences</title>
<title level="j" type="abbreviated">Can. j. neurol. sci.</title>
<idno type="ISSN">0317-1671</idno>
<imprint><date when="1999">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Canadian journal of neurological sciences</title>
<title level="j" type="abbreviated">Can. j. neurol. sci.</title>
<idno type="ISSN">0317-1671</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Agonist</term>
<term>Antiparkinson agent</term>
<term>Chemotherapy</term>
<term>D2 Dopamine receptor</term>
<term>Human</term>
<term>Parkinson disease</term>
<term>Pramipexole</term>
<term>Ropinirole</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Ropinirole</term>
<term>Agoniste</term>
<term>Récepteur dopaminergique D2</term>
<term>Pramipexole</term>
<term>Antiparkinsonien</term>
<term>Chimiothérapie</term>
<term>Traitement</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0317-1671</s0>
</fA01>
<fA02 i1="01"><s0>CJNSA2</s0>
</fA02>
<fA03 i2="1"><s0>Can. j. neurol. sci.</s0>
</fA03>
<fA05><s2>26</s2>
</fA05>
<fA06><s3>SUP2</s3>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Ropinirole and pramipexole, the new agonists</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Parkinson's Disease: Challenges and New Advances: Presentations of a series of regional educational programs in 1998</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>HOBSON (D. E.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>POURCHER (E.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>MARTIN (W. R. W.)</s1>
</fA11>
<fA14 i1="01"><s1>University of Manitoba</s1>
<s2>Winnipeg, Manitoba</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Laval University</s1>
<s2>Quebec City, Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>University of Alberta</s1>
<s2>Edmonton, Alberta</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA20><s2>S27-S33</s2>
</fA20>
<fA21><s1>1999</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA24 i1="01"><s0>fre</s0>
</fA24>
<fA43 i1="01"><s1>INIST</s1>
<s2>17449</s2>
<s5>354000089421960050</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1999 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>53 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>99-0456205</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Canadian journal of neurological sciences</s0>
</fA64>
<fA66 i1="01"><s0>CAN</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02B06</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Ropinirole</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Ropinirole</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Ropinirol</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Agoniste</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Agonist</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Agonista</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Récepteur dopaminergique D2</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>D2 Dopamine receptor</s0>
<s5>06</s5>
<s6>«D2» Dopamine receptor</s6>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Receptor dopaminérgico D2</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Pramipexole</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Pramipexole</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Pramipexol</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Antiparkinsonien</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Antiparkinson agent</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Antiparkinsoniano</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>16</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>16</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>16</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Traitement</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Treatment</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fN21><s1>291</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001183 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001183 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:99-0456205
   |texte=   Ropinirole and pramipexole, the new agonists
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

Ropinirole and pramipexole, the new agonists

Ropinirole and pramipexole, the new agonists

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri